Breast Cancer

US LABS Meets the ASCO/CAP Her-2 Guidelines

Published in Lab Business Week, March 25th, 2007

The American Society of Clinical Oncology (ASCO) and College of American Pathologists (CAP)recently released Guideline Recommendations for Human pidermal Growth Factor Receptor 2 (HER-2)Testing in Breast Cancer. These recommendations were published in the Journal of Clinical Oncology and the Archives of Pathology and Laboratory Medicine.1

The guidelines recognize that accurate identification of breast cancers overexpressing HER-2 is critical for identifying patients most likely to respond to agents that target HER-2, such as trastuzumab-based therapy (Herceptin(R)), while minimizing the potential impact of serious treatment-associated side effects.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week

Source: Lab Business Week (2007-03-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry